Cline Christopher R. (CIK 0001943192)

Latest company ownership

Shares held
112,083
Last filed at
Dec 3, 2025
Confidence Score
28.3
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 1, 2025 Dec 3, 2025 Travere Therapeutics, Inc. CFO Sell 17.5 -20,000 -17.84% $700.2K
Sep 3, 2025 Sep 5, 2025 Travere Therapeutics, Inc. CFO Sell 51.3 -573 -0.62% $10.6K
Aug 27, 2025 Aug 28, 2025 Travere Therapeutics, Inc. CFO Sell 52.5 -470 -0.50% $8.1K
May 2, 2025 May 5, 2025 Travere Therapeutics, Inc. CFO Sell 46.3 -1,784 -1.88% $37.6K
Apr 11, 2025 Apr 14, 2025 Travere Therapeutics, Inc. CFO Sell 52.5 -48 -0.05% $630.9
Jan 31, 2025 Feb 4, 2025 Travere Therapeutics, Inc. CFO Sell 95.0 +16,308 22.12% $104.5K
Jan 22, 2025 Jan 23, 2025 Travere Therapeutics, Inc. CFO Sell 46.3 -865 -1.16% $16.4K
Sep 5, 2024 Sep 9, 2024 Travere Therapeutics, Inc. CFO Sell 86.3 +4,260 6.06% $28.7K
Sep 4, 2024 Sep 5, 2024 Travere Therapeutics, Inc. CFO Sell 50.0 -514 -0.73% $4.9K
Apr 11, 2024 Apr 12, 2024 Travere Therapeutics, Inc. CFO Sell 52.5 -54 -0.08% $364
Jan 31, 2024 Feb 2, 2024 Travere Therapeutics, Inc. CFO Sell 91.3 +21,182 42.60% $32.6K
Jan 23, 2024 Jan 25, 2024 Travere Therapeutics, Inc. CFO Sell 47.5 -853 -1.69% $7.7K
Sep 5, 2023 Sep 5, 2023 Travere Therapeutics, Inc. CFO Sell 50.0 -457 -0.90% $6.7K
May 10, 2023 May 12, 2023 Travere Therapeutics, Inc. CFO Sell 50.0 -455 -0.88% $7.5K
Apr 11, 2023 Apr 13, 2023 Travere Therapeutics, Inc. CFO Sell 52.5 -47 -0.09% $1K
Jan 31, 2023 Feb 2, 2023 Travere Therapeutics, Inc. CFO Sell 91.3 +18,662 56.77% $34.5K
Jan 24, 2023 Jan 26, 2023 Travere Therapeutics, Inc. CFO Sell 46.3 -852 -2.53% $18.7K